[Influence of lipid infusions (Lipofundin) on serum electrolytes, renal clearance and electrolyte excretion in healthy subjects and patients with kidney diseases].
D000686:Amyloidosis / Q000378:metabolism; D004573:Electrolytes / Q000378:metabolism*; D005921:Glomerulonephritis / Q000378:metabolism; D006801:Humans; D007275:Injections, Intravenous; D007668:Kidney / Q000378:metabolism; D007674:Kidney Diseases / Q000378:metabolism*; D050356:Lipid Metabolism; D008055:Lipids / Q000008:administration & dosage*; D009401:Nephrosis / Q000378:metabolism; D011188:Potassium / Q000097:blood / Q000652:urine; D012964:Sodium / Q000097:blood / Q000652:urine
D004573:Electrolytes; D008055:Lipids; D012964:Sodium; D011188:Potassium
Der Einfluss von Fettinfusionen (Lipofundin) auf Serumelektrolyte, Nieren-Clearance und Elektrolytausscheidung bei Gesunden und Nierenkranken.